Literature DB >> 5360814

The significance of the blood glucose level for plasma insulin response to intravenously administered tolbutamide in healthy subjects.

E Cerasi, I Chowers, R Luft, A Widström.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 5360814     DOI： 10.1007/bf00452910

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  17 in total

1.  Immunoassay of insulin with insulin-antibody precipitate.

Authors:  C N HALES; P J RANDLE
Journal:  Biochem J       Date:  1963-07       Impact factor: 3.857

2.  Comparison of plasma insulin levels following administration of tolbutamide and glucose.

Authors:  R S YALOW; H BLACK; M VILLAZON; S A BERSON
Journal:  Diabetes       Date:  1960 Sep-Oct       Impact factor: 9.461

3.  A new diagnostic procedure for mild diabetes mellitus; evaluation of an intravenous tolbutamide response test.

Authors:  R H UNGER; L L MADISON
Journal:  Diabetes       Date:  1958 Nov-Dec       Impact factor: 9.461

Review 4.  [Stimulators and inhibitors of insulin secretion. Physiological and pharmacological interferences. Synergisms and antagonisms].

Authors:  A Loubatières
Journal:  Acta Diabetol Lat       Date:  1968-10

5.  Presence and mobilization of glycogen in mammalian pancreatic beta cells.

Authors:  B Hellman; L A Idahl
Journal:  Endocrinology       Date:  1969-01       Impact factor: 4.736

6.  Stimulation of insulin secretion by noncarbohydrate metabolites.

Authors:  W J Malaisse; F Malaisse-Lagae
Journal:  J Lab Clin Med       Date:  1968-09

7.  Further studies on healthy subjects with low and high insulin response to glucose infusion.

Authors:  E Cerasi; R Luft
Journal:  Acta Endocrinol (Copenh)       Date:  1967-06

8.  Regulation of insulin secretion studied with pieces of rabbit pancreas incubated in vitro.

Authors:  H G Coore; P J Randle
Journal:  Biochem J       Date:  1964-10       Impact factor: 3.857

9.  Interrelationship of glucagon, insulin and glucose. The insulinogenic effect of glucagon.

Authors:  E Samols; G Marri; V Marks
Journal:  Diabetes       Date:  1966-12       Impact factor: 9.461

10.  The effect of epinephrine on immunoreactive insulin levels in man.

Authors:  D Porte; A L Graber; T Kuzuya; R H Williams
Journal:  J Clin Invest       Date:  1966-02       Impact factor: 14.808
View more
  7 in total

1.  Role of plasma free fatty acids in the control of insulin secretion in man.

Authors:  E O Balasse; H A Ooms
Journal:  Diabetologia       Date:  1973-04       Impact factor: 10.122

Review 2.  Insulin and oral hypoglycaemic agents. I. Physiological and clinical pharmacological aspects.

Authors:  H D Breidahl; G C Ennis; F I Martin; J R Stawell; P Taft
Journal:  Drugs       Date:  1972       Impact factor: 9.546

3.  A threshold distribution hypothesis for packet storage of insulin and its mathematical modeling.

Authors:  G M Grodsky
Journal:  J Clin Invest       Date:  1972-08       Impact factor: 14.808

4.  [Comparative studies of the oral and intravenous tolbutamide test. II. Determination of glucose, serum-insulin and serum-tolbutamide in normal young subjects].

Authors:  P Berchtold; V Büber; V Meier; J P Felber; G Keiser
Journal:  Diabetologia       Date:  1971-04       Impact factor: 10.122

5.  Effect of glucose/sulfonylurea interaction on release of insulin, glucagon, and somatostatin from isolated perfused rat pancreas.

Authors:  S Efendić; F Enzmann; A Nylén; K Uvnäs-Wallensten; R Luft
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

6.  Plasma insulin and surgery. II. Later changes and the effect of intravenous carbohydrates.

Authors:  A E Giddings; B J Rowlands; D Mangnall; R G Clark
Journal:  Ann Surg       Date:  1977-12       Impact factor: 12.969

7.  Characterisation of the effect of intravenous infusion of glucose and tolbutamide on the insulin delivery rate in man.

Authors:  T Asano; H Sasaki; M Okumura
Journal:  Diabetologia       Date:  1978-09       Impact factor: 10.122
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.